{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T22:52:13Z","timestamp":1792363933788,"version":"4.4.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T00:00:00Z","timestamp":1777075200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.clinthera.2026.04.020","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T20:21:10Z","timestamp":1779481270000},"page":"790-797","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy and Safety of Inhalational Insulin Compared With Rapid-Acting Insulin Analogs: A Systematic Review and Meta-Analysis"],"prefix":"10.1016","volume":"48","author":[{"given":"Ratnesh","family":"Sinha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8062-7131","authenticated-orcid":false,"given":"Sameer","family":"Uz Zaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rehna C.","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alok","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepanshi","family":"Saxena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayan Kumar","family":"Pati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2026.04.020_bib0001","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.sapharm.2023.11.009","article-title":"The prevalence of adherence to insulin therapy in patients with diabetes: a systematic review and meta-analysis","volume":"20","author":"Boonpattharatthiti","year":"2024","journal-title":"Res Soc Adm Pharm RSAP"},{"key":"10.1016\/j.clinthera.2026.04.020_bib0002","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2021-002373","article-title":"100 years on: the impact of the discovery of insulin on clinical outcomes","volume":"9","author":"Buse","year":"2021","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/j.clinthera.2026.04.020_bib0003","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1007\/s13300-023-01468-4","article-title":"Insulin therapy for the management of diabetes mellitus: a narrative review of innovative treatment strategies","volume":"14","author":"Nkonge","year":"2023","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.clinthera.2026.04.020_bib0004","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1007\/s00592-022-01938-4","article-title":"Insulin: evolution of insulin formulations and their application in clinical practice over 100 years","volume":"59","author":"Bolli","year":"2022","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.clinthera.2026.04.020_bib0005","article-title":"9. Pharmacologic approaches to glycemic treatment: standards of care in diabetes\u20142023","volume":"46","author":"ElSayed","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clinthera.2026.04.020_bib0006","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1177\/193229680800200325","article-title":"The failure of Exubera: are we beating a dead horse?","volume":"2","author":"Heinemann","year":"2008","journal-title":"J Diabetes Sci Technol Online"},{"key":"10.1016\/j.clinthera.2026.04.020_bib0007","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2024.1366368","article-title":"Current barriers to initiating insulin therapy in individuals with type 2 diabetes","volume":"15","author":"Gald\u00f3n Sanz-Pastor","year":"2024","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.clinthera.2026.04.020_bib0008","doi-asserted-by":"crossref","first-page":"664","DOI":"10.3390\/biomedicines11030664","article-title":"Current development of chemical penetration enhancers for transdermal insulin delivery","volume":"11","author":"Sugumar","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.clinthera.2026.04.020_bib0009","doi-asserted-by":"crossref","first-page":"46","DOI":"10.4158\/EP14252.OR","article-title":"Fear of needles in children with type 1 diabetes mellitus on multiple daily injections and continuous subcutaneous insulin infusion","volume":"21","author":"Cemeroglu","year":"2015","journal-title":"Endocr Pract"},{"key":"10.1016\/j.clinthera.2026.04.020_bib0010","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.2337\/dc15-0075","article-title":"Inhaled Technosphere insulin compared with injected prandial insulin in type 1 diabetes: a randomized 24-week trial","volume":"38","author":"Bode","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clinthera.2026.04.020_bib0011","doi-asserted-by":"crossref","first-page":"240","DOI":"10.2337\/dc09-1348","article-title":"Correlates of insulin injection omission","volume":"33","author":"Peyrot","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clinthera.2026.04.020_bib0012","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1185\/03007990903073654","article-title":"Epidemiology and correlates of weight worry in the multinational diabetes attitudes, wishes and needs study","volume":"25","author":"Peyrot","year":"2009","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.clinthera.2026.04.020_bib0013","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/dme.13525","article-title":"Optimal prandial timing of bolus insulin in diabetes management: a review","volume":"35","author":"Slattery","year":"2018","journal-title":"Diabet Med"},{"key":"10.1016\/j.clinthera.2026.04.020_bib0014","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1111\/dom.14773","article-title":"What is the value of faster acting prandial insulin? Focus on ultra rapid lispro","volume":"24","author":"Heise","year":"2022","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.clinthera.2026.04.020_bib0015","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2147\/VHRM.S6098","article-title":"Inhaled insulin: overview of a novel route of insulin administration","volume":"6","author":"Mastrandrea","year":"2010","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.clinthera.2026.04.020_bib0016","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/4568903","article-title":"Rethinking the viability and utility of inhaled insulin in clinical practice","volume":"2018","author":"Heinemann","year":"2018","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.clinthera.2026.04.020_bib0017","doi-asserted-by":"crossref","first-page":"539","DOI":"10.2165\/00003088-200443080-00004","article-title":"Insulin disposition in the lung following oral inhalation in humans : a meta-analysis of its pharmacokinetics","volume":"43","author":"Sakagami","year":"2004","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.clinthera.2026.04.020_bib0018","doi-asserted-by":"crossref","first-page":"180","DOI":"10.2337\/diaspect.29.3.180","article-title":"Commentary: why was inhaled insulin a failure in the market?","volume":"29","author":"Oleck","year":"2016","journal-title":"Diabetes Spectr Publ Am Diabetes Assoc"},{"key":"10.1016\/j.clinthera.2026.04.020_bib0019","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1089\/dia.2018.0200","article-title":"Improved postprandial glucose with inhaled Technosphere insulin compared with insulin aspart in patients with type 1 diabetes on multiple daily injections: the STAT study","volume":"20","author":"Akturk","year":"2018","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.clinthera.2026.04.020_bib0020","unstructured":"CDSCO Approves Afrezza\u00ae (insulin human) Inhalation Powder in India | MannKind Corporation. Available from: https:\/\/investors.mannkindcorp.com\/news-releases\/news-release-details\/cdsco-approves-afrezzar-insulin-human-inhalation-powder-india"},{"key":"10.1016\/j.clinthera.2026.04.020_bib0021","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372:1-9","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.clinthera.2026.04.020_bib0022","unstructured":"Cochrane Handbook for Systematic Reviews of Interventions | Cochrane. Available from: https:\/\/www.cochrane.org\/authors\/handbooks-and-manuals\/handbook"},{"key":"10.1016\/j.clinthera.2026.04.020_bib0023","doi-asserted-by":"crossref","DOI":"10.1177\/15209156261420176","article-title":"Inhaled Technosphere insulin in children with diabetes: the INHALE-1 extension study","author":"Beck","year":"2026","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.clinthera.2026.04.020_bib0024","unstructured":"Chapter 12: Synthesizing and presenting findings using other methods. Cochrane. Available from: https:\/\/www.cochrane.org\/authors\/handbooks-and-manuals\/handbook\/current\/chapter-12"},{"key":"10.1016\/j.clinthera.2026.04.020_bib0025","unstructured":"Chapter 10: Analysing data and undertaking meta-analyses | Cochrane. Available from: https:\/\/www.cochrane.org\/authors\/handbooks-and-manuals\/handbook\/current\/chapter-10"},{"key":"10.1016\/j.clinthera.2026.04.020_bib0026","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13643-023-02217-1","article-title":"Ten circumstances and solutions for finding the sample mean and standard deviation for meta-analysis","volume":"12","author":"Chi","year":"2023","journal-title":"Syst Rev"},{"key":"10.1016\/j.clinthera.2026.04.020_bib0027","doi-asserted-by":"crossref","first-page":"494","DOI":"10.11124\/JBIES-22-00430","article-title":"The revised JBI critical appraisal tool for the assessment of risk of bias for randomized controlled trials","volume":"21","author":"Barker","year":"2023","journal-title":"JBI Evid Synth"},{"key":"10.1016\/j.clinthera.2026.04.020_bib0028","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/1753-0407.13099","article-title":"Understanding inhaled Technosphere insulin: results of an early randomized trial in type 1 diabetes mellitus","volume":"13","author":"McGill","year":"2021","journal-title":"J Diabetes"},{"key":"10.1016\/j.clinthera.2026.04.020_bib0029","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/dme.14202","article-title":"Hypoglycaemia is reduced with use of inhaled Technosphere\u00ae insulin relative to insulin aspart in type 1 diabetes mellitus","volume":"37","author":"Seaquist","year":"2020","journal-title":"Diabet Med"},{"key":"10.1016\/j.clinthera.2026.04.020_bib0030","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.eprac.2020.11.002","article-title":"Results of a 24-week trial of Technosphere insulin versus insulin aspart in type 2 diabetes","volume":"27","author":"Hoogwerf","year":"2021","journal-title":"Endocr Pract"},{"key":"10.1016\/j.clinthera.2026.04.020_bib0031","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2337\/dc25-1994","article-title":"INHALE-1: a multicenter randomized trial of inhaled Technosphere insulin in children with type 1 diabetes","volume":"49","author":"Haller","year":"2026","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clinthera.2026.04.020_bib0032","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2337\/dc24-1832","article-title":"A randomized trial comparing inhaled insulin plus basal insulin versus usual care in adults with type 1 diabetes","volume":"48","author":"Hirsch","year":"2025","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clinthera.2026.04.020_bib0033","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1089\/dia.2024.0581","article-title":"A 13-week single-arm evaluation of inhaled Technosphere insulin plus insulin degludec for adults with type 1 diabetes","volume":"27","author":"Beck","year":"2025","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.clinthera.2026.04.020_bib0034","doi-asserted-by":"crossref","DOI":"10.1177\/19322968251388128","article-title":"Replacing or supplementing automated insulin delivery with inhaled insulin: a 90-day randomized controlled trial","author":"Kaiserman","year":"2025","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/j.clinthera.2026.04.020_bib0035","unstructured":"Halsey G. FDA accepts MannKind sBLA for inhaled insulin for children and adolescents with diabetes. Patient Care Online. 2025. Available from: https:\/\/www.patientcareonline.com\/view\/fda-accepts-mannkind-sbla-for-inhaled-insulin-for-children-and-adolescents-with-diabetes"},{"key":"10.1016\/j.clinthera.2026.04.020_bib0036","unstructured":"MannKind announces U.S. FDA accepts for review its supplemental biologics license application (sBLA) for inhaled insulin (Afrezza) in children and adolescents aged 4-17 years living with diabetes | MannKind Corporation. Available from: https:\/\/investors.mannkindcorp.com\/news-releases\/news-release-details\/mannkind-announces-us-fda-accepts-review-its-supplemental"},{"key":"10.1016\/j.clinthera.2026.04.020_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2025.109108","article-title":"Technosphere insulin in the treatment of type 1 diabetes mellitus: a systematic review and meta-analysis","volume":"39","author":"Santos","year":"2025","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.clinthera.2026.04.020_bib0038","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/S2213-8587(15)00280-6","article-title":"Efficacy, safety, and patient acceptability of Technosphere inhaled insulin for people with diabetes: a systematic review and meta-analysis","volume":"3","author":"Pittas","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1_Suppl","key":"10.1016\/j.clinthera.2026.04.020_bib0039","doi-asserted-by":"crossref","first-page":"19S","DOI":"10.1177\/15209156251396118","article-title":"Pulmonary safety and clinical considerations for inhaled insulin: a comprehensive review","volume":"28","author":"McGill","year":"2026","journal-title":"Diabetes Technol Ther"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291826001384?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291826001384?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T14:02:22Z","timestamp":1783692142000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291826001384"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":39,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0149291826001384"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2026.04.020","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and Safety of Inhalational Insulin Compared With Rapid-Acting Insulin Analogs: A Systematic Review and Meta-Analysis","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2026.04.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}